Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Vale SA (VALE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Vale SA — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.97 (market cap $31.07B), while Vale SA trades at $13.03 (market cap $57.30B). The key difference: Vale SA is the larger of the two by market cap, and Vale SA pays the higher dividend (8.9%). Which is the better fit depends on your goals.
| GEHC | VALE | |
|---|---|---|
Market Cap | $31.07B | $57.30B |
Volume | 3,443,020 | 25,010,417 |
Sector | Health | Basic Materials |
52-Week High | $88.16 | $17.82 |
52-Week Low | $59.48 | $11.10 |
Enterprise Value | $39.53B | $73.54B |
Dividend Yield | 0.23% | 8.9% |
Typical Hold Time | — | 110 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
VALE trades at $13.37, down 1.11% today, with a bearish technical signal and recent earnings misses. The company reported $38.4B revenue in 2025 with net income of $2.35B, though profit margins have compressed from 42.85% in 2022 to 6.12% in 2025. Analyst consensus is mixed with 32% buy ratings and a $15.93 price target, while recent news highlights cost pressures and regulatory risks in Brazil.
The outlook remains cautious due to cyclical exposure to iron ore prices and rising operational costs. While the base metals segment shows growth potential, near-term headwinds from margin compression and earnings volatility suggest limited upside. The stock offers a dividend yield but faces significant execution and commodity price risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Vale SA
Vale is the world's largest iron ore miner and one of the largest diversified miners, along with BHP and Rio Tinto. Earnings are dominated by the bulk materials division, primarily iron ore and iron ore pellets, with minor contributions from iron ore proxies, including manganese and coal. The base metals division is much smaller, primarily consisting of nickel mines and smelters with a small contribution from copper.
Read more on VALE →
